CYT107
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CYT107, covering 2013-08-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) [Phase 2]